List of bibliographic references
Number of relevant bibliographic references: 12.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 3 | Antirheumatic Agents (adverse effects) |
| 3 | Female |
| 3 | Humans |
| 2 | Adult |
| 2 | Antibodies, Monoclonal, Humanized (adverse effects) |
| 2 | Arthritis, Rheumatoid (drug therapy) |
| 2 | France (epidemiology) |
| 2 | Male |
| 2 | Middle Aged |
| 1 | |
| 1 | Abatacept (administration & dosage) |
| 1 | Abatacept (adverse effects) |
| 1 | Aged |
| 1 | Antibodies, Monoclonal (adverse effects) |
| 1 | Antibodies, Monoclonal, Humanized |
| 1 | Antibodies, Monoclonal, Humanized (administration & dosage) |
| 1 | Antirheumatic Agents (administration & dosage) |
| 1 | Arthritis, Rheumatoid (blood) |
| 1 | Arthritis, Rheumatoid (diagnosis) |
| 1 | Arthritis, Rheumatoid (epidemiology) |
| 1 | Autoantibodies (blood) |
| 1 | Biological Factors (therapeutic use) |
| 1 | Canakinumab |
| 1 | Cohort Studies |
| 1 | Drug Monitoring (methods) |
| 1 | Drug Monitoring (statistics & numerical data) |
| 1 | Drug Resistance |
| 1 | Drug Therapy, Combination |
| 1 | Drug Therapy, Combination (methods) |
| 1 | Drug Therapy, Combination (statistics & numerical data) |
| 1 | Hemophagocytic syndrome |
| 1 | Immunoglobulins |
| 1 | Immunomodulator |
| 1 | Incidence |
| 1 | Interleukin-1beta (antagonists & inhibitors) |
| 1 | Isoxazoles (adverse effects) |
| 1 | Leflunomide |
| 1 | Leukocyte Count |
| 1 | Macrophage Activation Syndrome (etiology) |
| 1 | Neutrophils |
| 1 | Opportunistic Infections (chemically induced) |
| 1 | Opportunistic Infections (epidemiology) |
| 1 | Outcome Assessment, Health Care |
| 1 | Peptides, Cyclic (immunology) |
| 1 | Proportional Hazards Models |
| 1 | Prospective Studies |
| 1 | Registries |
| 1 | Rheumatology |
| 1 | Risk Factors |
| 1 | Rituximab (administration & dosage) |
| 1 | Rituximab (adverse effects) |
| 1 | Still disease |
| 1 | Still's Disease, Adult-Onset (complications) |
| 1 | Still's Disease, Adult-Onset (drug therapy) |
| 1 | Survival Analysis |
| 1 | Tumor Necrosis Factor-alpha (antagonists & inhibitors) |
| 1 | corticosteroids |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Olivier Vittecoq"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Olivier Vittecoq" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Olivier Vittecoq
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
